Summary
The immunoglobulin class and IgG subclass distribution of anti-Vi antibodies elicited by vaccination with a single injection of the purified polysaccharide or three injections of the inactivated whole cell typhoid vaccine was examined using an immunoenzymatic assay. The two vaccines induced antibody responses of similar magnitude and the predominant subclass of IgG antibodies was IgG1.
Similar content being viewed by others
References
Acharya IL, Lowe CU, Thapa R, Gurubachary VL, Shrestha MB, Cadoz M, Schulz D, Armand J, Bryla DA, Trollfors B, Cramton T, Schneerson R, Robbins JB, Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide ofSalmonella typhi. A preliminary report. N Engl J Med 317: 1101, 1987
Amir J, Scott MG, Nham MH, Granoff DM, Bactericidal and opsonic activity of IgG1 and IgG2 anticapsular antibodies toHaemophilus influenzae type b. J Infect Dis 162: 163, 1990
Barra A, Schulz D, Aucouturier P, Preud’homme JL, Measurement of anti-Haemophilus influenzae type b capsular polysaccharide antibodies by ELISA. J Immunol Methods 115: 111, 1988
Barret TJ, Blake PA, Brown SL, Hoffman K, Mateu Llort JM, Feeley JC, Enzyme-linked immunosorbent assay for detection of antibodies ofSalmonella typhi Vi antigen. J Clin Microbiol 17: 625, 1983
Bencic Z, Typhoid vaccines. Lancet II: 682, 1987
Black RE, Levine MM, Ferreccio C, Clements ML, Lanata C, Rooney J, Germanier R, Efficacy of one or two doses or Ty21aSalmonella typhi vaccine in enteric-coated capsules in a controlled field trial. Chilean Typhoid Committee. Vaccine 8: 81, 1990
Cryz SJ, Furer E, Baron LS, Noon KF, Rubin FA, Kopecko DJ, Construction and characterization of a Vi-positive variant of theSalmonella typhi live oral vaccine strain Ty21a. Infect Immun 57: 3863, 1989
Forrest BD, LaBrooy JT, Beyer L, Dearlove CE, Shearman DJ The human humoral immune response toSalmonella typhi Ty21a. J Infect Dis 163: 336, 1991
Forrest BD, LaBrooy JT, Dearlove CE, Shearmn DJ, Effect of parenteral immunization on the intestinal immune response toSalmonella typhi Ty21a. Infect Immun 60: 465, 1992
Gaines S, Currie JA, Tully JG, Production of incomplete Vi antibody in man by typhoid vaccine. Am J Epidemiol 81: 350, 1965
Hackett J, Salmonella-based vaccines. Vaccine 8: 5, 1990
Hammarstrom L, Insel RA, Persson MAA, Smith CIE, The IgG1 subclass preference of selected, naturally occurring antipolysaccharide antibodies. Monogr Allergy 23: 18, 1988
Kantele A, Makela PH, Different profiles of the human immune response to primary and secondary immunization with an oralSalmonella Ty21a vaccine. Vaccine 9: 423, 1991
Klugman KP, Gilbertson IT, Koornhof HJ, Robbins JB, Schneerson R, Schulz D, Cadoz, Armand J, Protective activity of Vi capsular polysaccharide vaccine against typhoid fever. Lancet I: 1165, 1987
Levine MM, Ferreccio C, Black RE, Tacket CO, Germanier R, Progress in vaccines against typhoid fever. Rev Infect Dis 11: S552, 1989
Levine MM, Ferreccio C, Cryz S, Ortiz E, Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trial. Lancet 336: 891, 1990
Levine MM, Hone D, Tacket C, Ferreccio C, Cryz S, Clinical and field trials with attenuatedSalmonella typhi as live oral vaccines and as “carrier” vaccines. Res Microbiol 141: 807, 1990
Losonsky GA, Ferreccio C, Kotloff KL, Kaintuck S, Robbins JB, Levine MM, Development and evaluation of an enzymelinked immunosorbent assay for serum Vi antibodies for detection of chronicSalmonella typhi carriers. J Clin Microbiol 25: 2266, 1987
Makela O, Matilla P, Rautonen N, Seppala I, Eskola J, Kayhty H, Isotype concentrations of human antibodies toHaemophilus influenzae type b polysaccharide (Hib) in young adults immunized with the polysaccharide as such or conjugated to a protein (diphtheria toxoid). J Immunol 139: 1999, 1987
Murphy JR, Crez L, Schlesinger L, Ferreccio C, Baqar S, Munoz C, Wasserman SS, Losonsky G, Olson JG, Levine MM, Immunogenicity ofSalmonella typhi Ty21a vaccine for young children. Infect Immun 59: 4291, 1991
Persson MAA, Ekwall E, Hammarstrom L, Lindberg AA, Smith CIE, IgG and IgA subclass patterns of human antibodies toShigella flexneri andSalmonella subgroups B and D 0 antigens. Infect Immun 52: 834, 1983
Robbins JD, Robbins JB, Re-examination of the protective role of the capsular polysaccharide (Vi antigen) ofSalmonella typhi. J Infect Dis 150: 436, 1984
Shackelford PG, Granoff DM, IgG subclass composition of the antibody response of healthy adults and normal or IgG2-deficient children to immunization withHaemophilus influenzae type b polysaccharide vaccine or Hib PS-protein conjugate vaccines. Monogr Allergy 23: 269, 1988
Simanjuntak CH, Paleologo FP, Punjabi NH, Darmowigoto R, Soeprawoto A, Totosudirjo H, Haryanto P, Suprijanto E, Witham ND, Hoffman SL, Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine. Lancet 338: 1055, 1991
Tacket CO, Ferreccio C, Robbins JB, Tsai CM, Schulz D, Cadoz M, Goudeau A, Levine MM, Safety and immunogenicity of twoSalmonella typhi Vi capsular polysaccharide vaccines. J Infect Dis 154: 342, 1986
Tacket CO, Hone DM, Curtiss R, Kelly SM, Losonsky G, Guers L, Harris AM, Edelman R, Levine MM, Comparison of the safety and immunogenicity of delta aroC delta aroD and delta cya delta crpSalmonella typhi strains in adult volunteers. Infect Immun 60: 536, 1992
Weinberg GA, Granoff DM, Nahm MH, Shackelford PG, Functional activity of different IgG subclass antibodies against type b capsular polysaccharide ofHaemophilus influenzae. J Immunol 136: 4232, 1986
Wong KH, Feeley JC, Isolation of Vi antigen and a simple method for its measurement. Appl Microbiol 24: 628, 1972
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brugier, JC., Barra, A., Schulz, D. et al. Isotypes of human vaccinal antibodies to the Vi capsular polysaccharide ofSalmonella typhi . Int J Clin Lab Res 23, 38–41 (1993). https://doi.org/10.1007/BF02592279
Issue Date:
DOI: https://doi.org/10.1007/BF02592279